Diagnosis of limited ophthalmic wegener granulomatosis: Distinctive pathologic features with ANCA test confirmation

International Ophthalmology

Volumn 28, Issue 1, 2008, Pages 35-46

  Ahmed, Muna ^a   Niffenegger, John H ^b   Jakobiec, Frederick Albert ^c   Ben Arie Weintrob, Yael ^a   Gion, Nicolette ^a   Androudi, Sofia ^a   Folberg, Robert ^d   Raizman, Michael B ^e   Margo, Curtis E ^f   Smith, Morton E ^g   McLean, Ian W ^h   Caya, James G ⁱ   Foster, C Stephen ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Sarasota Retina Institute   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

ⁱ Medical Assessment and Consultation SC   (United States)

Author keywords

ANCA; Histopathology; Limited; Ophthalmic Wegener's

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; NAFCILLIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELL INFILTRATION; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG DOSE REDUCTION; EOSINOPHIL; EPISCLERITIS; EYE BIOPSY; EYE DISEASE; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUTROPHIL; ORBIT DISEASE; OTITIS MEDIA; PARANASAL SINUS DISEASE; PLASMA CELL; SCLERITIS; STAPHYLOCOCCUS INFECTION; TISSUE NECROSIS; UVEITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYCLOPHOSPHAMIDE; DACRYOCYSTITIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; ORBITAL DISEASES; PANUVEITIS; PREDNISONE; SCLERITIS; TOMOGRAPHY, X-RAY COMPUTED; VISUAL ACUITY; WEGENER GRANULOMATOSIS;

EID: 39749099965     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9109-y     Document Type: Article

References (37)

1. Straatsma BR (1957) Ocular manifestations of Wegener granulomatosis. Am J Ophthalmol 44:789-799
2. Wegener F (1939) Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems under Nieren. Beitr Pathol 102:36-68
3. Kornblut AD, Wolff SM, deFries HO, Fauci AS (1982) Wegener's granulomatosis. Otolaryngol Clin North Am 15:673-683
4. Godman GC, Churg J (1954) Wegener's granulomatosis: Pathology and review of the literature. AMA Arch Pathol 58:533-553
5. Saleh A, Stone JH (2005) Classification and diagnostic criteria in systemic vasculitis. Best Pract Res Clin Rheumatol 19:209-221
6. Carrington CB, Liebow AA (1966) Limited forms of angiitis and granulomatosis of the Wegener's type. Am J Med 41:497-527
7. Cassan SM, Coles DT, Harrison EG Jr (1970) The concept of limited forms of Wegener's granulomatosis. Am J Med 49:366-379
8. Nolle B, Specks U, Ludeman J et al (1989) Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 111:28-40
9. Tervaert JW, van der Woude FJ, Fauci AS et al (1989) Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461-2465
10. van Rossum AP, Limburg PC, Kallenberg CG (2003) Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis. Clin Exp Rheumatol 21:S64-S68
11. Wolff SM, Fauci AS, Horn RG, Dale DC (1974) Wegener's granulomatosis. Ann Int Med 81:513-525
12. Jakobiec FA, Jones IS (1989) Orbital inflammations. In: Tasman W, Jaeger EA (eds) Duane's clinical ophthalmology, Rev ed., vol 2, chap 35, JB Lippincott, Philadelphia 1989
13. Coppeto JR, Yamase H, Monteiro MLR (1985) Chronic ophthalmic Wegener's granulomatosis. J Clin Neuroophthalmol 5:17-25
14. Kuchel J, Lee S (2003) Cutaneous Wegener's granulomatosis: A variant or atypical localized form? Australas J Dermatol 44:129-135
15. Harper SL, Letko E, Samson CM et al (2001) Wegener's granulomatosis: The relationship between ocular and systemic disease. J Rheumatol 28:1025-1032
16. Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76-85
17. Austin P, Green WR, Sallyer DC et al (1978) Peripheral corneal degeneration and occlusive vasculitis in Wegener's granulomatosis. Am J Ophthalmol 85:311-317
18. Brubaker R, Font RL, Shepherd EM (1971) Granulomatous sclerouveitis. Regression of ocular lesions with cyclophosphamide and prednisone. Arch Ophthalmol 86:517-524
19. Foster CS, Yee M (1983) Corneoscleral manifestations of Grave's disease, the acquired connective tissue disorders, and systemic vasculitis. Int Ophthalmol Clin 23:131-157
20. Bullen CL, Liesegang TJ, MacDonald TJ, DeRemee RA (1983) Ocular complications of Wegener's granulomatosis. Ophthalmology 90:279-290
21. Jakobiec FA (1979) Disease of the orbit (pp 216-271). New York, Harper & Row
22. Hardwig PW, Bartley GB, Garrity JA (1992) Surgical management of nasolacrimal duct obstruction in patients with Wegener's granulomatosis. Ophthalmology 99:133-139
23. Leavitt JA, Butrus SI (1991) Wegener's granulomatosis presenting as dacryoadenitis. Cornea 10:542-545
24. Wegener F (1936) Über generalisierte, septische Gefässerkrankungen. Verh Dtsch Ges Pathol 29:202-210
25. McCluskey RT, Fienberg R (1983) Vasculitis in primary vasculitis, granulomatoses, and connective tissue diseases. Hum Pathol 14:305-315
26. Boudes P (1990) Purely granulomatous Wegener's granulomatosis: A new concept for an old disease. Semin Arthritis Rheum 19:365-370
27. Fienberg R (1981) The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis. Hum Pathol 12:458-467
28. Sergott RC, Felbert NT, Savino PJ et al (1981) The clinical immunopathology of Graves' orbitopathy. Ophthalmology 88:484-487
29. Jellinek EH (1969) The orbital pseudotumor syndrome and its differentiation from endocrine exophthalmos. Brain 92:35-58
30. Davies GB, Wong PL (1958) Sclerosing lipo-granuloma in the orbit. Br J Ophthalmol 42:697-701
31. Kalina PH, Lie JT, Campbell RJ, Garrity JA (1992) Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis. Ophthalmology 99:120-124
32. Perry SR, Rootman J, White VA (1997) The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology 104:683-694
33. Mastaglia FL, Ojeda VJ (1985) Inflammatory myopathies: Part 2. Ann Neurol 17:317-323
34. Kattah JC, Zimmerman LE, Kolsky MP et al (1990) Bilateral orbital involvement in fatal giant cell polymyositis. Ophthalmology 97:520-525
35. Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27:277-301
36. Woo TL, Francis IC, Wilcsek GA, Coroneo MT, McNab AA, Sullivan TJ (2001) Australasian orbital and adnexal wagener's study group. Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology 108:1535-1543
37. Hoffman GS, Kerr GS, Leavitt RY et al (1992) Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 15(116):488-498